| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |